NRXS
Neuraxis, INC
NASDAQ · Healthcare · Biotechnology · US
$7.85
+1.95%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 23.52x
- P/S forward
- 6.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 14.64x
- Price / sales
- 18.54x
- Price / cash flow
- -17.54x
Enterprise value
- Enterprise value
- $90.5M
- EV / sales
- 17.03x
- EV / EBITDA
- -12.07x
- EV / EBIT
- -11.79x
- Market cap
- $98.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026